In patients with ulcerative colitis a colon tissue bound IgG and serum antibodies against an Mr 40000 colonic protein(s) has been identified.
method, the protein was localised in human tissue exclusively to colonic epithelial cells. In this study the presence ofthe Mr 40 000 protein was assessed in experimental animals by the direct and inhibition enzyme linked immunosorbent assays (ELISAs) using the anti-Mr 40000 protein monoclonal antibody, 7E12H12
(IgM isotype). In addition, a total of 129 specimens including colon, small intestine, gall bladder, biliary tract, and kidney from nine strains ofrats and mice, and from human tissue were studied by the immunocytochemical method using 7E12H12. All colon specimens from both humans and animals reacted with 7E12H12 in the immunocytochemical and ELISA assays. None ofthe non-colonic organs reacted with 7E12H12. While in human colon 7E12H12 recognised the absorptive epithelial cells, in all the animals it recognised mainly the colonic goblet cells. Extracts of animal colon but not of small intestine inhibited the binding of 7E12H12 to the human colon extract. This study shows the presence of an organ specific Mr 40000 colonic epithelial protein(s) in humans and experimental animals. A differing cellular localisation of the Mr 40 000 protein (s) in human v animal tissue was also shown. Further characterisation of the Mr 40 000 protein(s) may provide important clues regarding the autoimmune mechanisms in ulcerative colitis.
Autoimmunity has been implicated in the pathogenesis of ulcerative colitis.'-" The precise nature of the involved autoantigen(s) and antibodies is unknown, however. We earlier reported the presence of an IgG antibody bound to colonic tissue from patients with ulcerative colitis and termed it CCA-IgG or colitis colon associated IgG antibody.'2 The CCA-IgG preferentially binds to colonic tissue extracts'3 containing an Mr 40 000 protein(s) from both normal and diseased colon. 14 (5) and small intestine (3); Wistar rat colon (11) and small intestine (5); Lewis rat colon (12) , small intestine (3), kidney (4), and biliary tract (6) ; Sprague Dawley rat colon (10) and small intestine (4); BALB/c mouse colon (12) , small intestine (7) , biliary tract (6) , gall bladder (4), and kidney (4); SJL mouse colon (9), small intestine (4), and biliary tract (4); B1O.D2 mouse colon (4); DB.A2 mouse colon (4); B6.D2.F11 mouse colon (4); and B6 mouse colon (4) . Samples of human colon and ileal tissue were obtained from normal subjects who underwent colonoscopy. The animals were sacrificed by cervical dislocation and specimens of colon, small intestine, kidneys, and biliary tract were fixed in 10% formalin. All (Fig 2) .
CROSS REACTIVITY BETWEEN ANIMAL AND HUMAN COLON EXTRACTS: INHIBITION ELISA
The cross reactivity of the antigen(s) present in the colon from humans, Wistar rats, Lewis rats, Sprague Dawley rats, BALB/c mice, and SJL mice was further investigated by using different colon extracts to compete with the Lewis rat colon extract and human colon extract for binding against 7E12H12 in an inhibition ELISA assay. Figure 3 and Table II show the cross reactivity among various species and the relative differences in the expression of the immunoreactive epitope(s). As Table II shows all the colon specimens tested were capable of inhibition, although at different concentrations. A 50% inhibition of the binding of 7E12H12 to the Lewis (Table II) . Inhibition of the binding of 7E12H12
to Lewis rat colon extract by different concentrations of colon and small intestine extracts from human, Lewis rats, and BALB/c mice is shown in Figure 3 . These data suggest a difference in the affinity of the Mr 40000 colonic protein to 7E12H12 among the different species. The highest specific immunoreactivity against 7E12H12 was present in the Lewis rats and BALB/c mice colon extracts (Fig 3 and Table II Figure 3 : Inhibition ELISA: the inhibition of 7E,2H,2 binding to Lewis rat colon extract by serial dilutions ofcolon or small intestine extract from humans, Lewis rats, and BALBIc mice. All the colon extracts, and none ofthe small intestine extracts, inhibited the binding of 7E,2H,2 to the antigen coating the plate. The inhibition was stronger using the Lewis rats and BALBIc mice colon extracts. not small intestine extracts (Table II) . The lowest amount of protein required to induce a 50% inhibition of the binding of 7E12H12 to the human colon extract was observed with colon extract from Lewis rats followed by homologous colon extract.
Discussion
In this study the presence of an Mr 40000 associated protein(s) has been shown in the colon from humans and various animals using the antiMr 40000 monoclonal antibody 7E12H12. The organ specificity of this protein in human tissue was shown earlier, '6 
